Osmotica to Present at Barclays Global Healthcare Conference 2020
Get Alerts OSMT Hot Sheet
Join SI Premium – FREE
BRIDGEWATER, N.J., March 03, 2020 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the “Company”), a fully integrated biopharmaceutical company, announced today that Brian Markison, Chief Executive Officer, and Andrew Einhorn, Chief Financial Officer, will present at the Barclays Global Healthcare Conference 2020 as follows:
| Date: | Tuesday, March 10, 2020 |
| Time: | 11:00 a.m. Eastern Time |
| Location: | Loews Miami Beach Hotel, Miami Beach, FL |
| Webcast: | https://cc.talkpoint.com/barc002/031020a_js/?entity=89_651TH2U |
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the non-promoted products including complex generic formulations.
Osmotica has operations in the United States, Argentina, and Hungary.
Investor and Media Relations for Osmotica Pharmaceuticals plcLisa M. WilsonIn-Site Communications, Inc.T: 212-452-2793E: [email protected]
Source: Osmotica Holdings US LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress
- Boutique Consultancy Challenging the Status Quo In the AI Era, with Project Advisory Group at the Forefront
- Michelin: Disclosure of trading in own shares - September 3rd, 2026
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share